Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

About IPC

The IPC Impact

  • Educated 1,500 health care providers who attended IPC virtual symposia

  • Trained another 1,000 clinicians via IPC online continuing medical education programs

  • Provided psoriasis resources, tools and information to 16,000 professionals

  • Provided 85,000 individuals with information on COVID-19 and psoriasis

    About IPC

    Our Strategic Plan

    IPC's plan for advancing  knowledge and enhancing  care for patients with psoriasis.

    About IPC

    2020 Annual Report

    Improving psoriasis care worldwide



    Latest news

    November 22, 2021
    The European Commission has approved SKYRIZI® for the treatment of active psoriatic arthritis in adults.
    November 18, 2021
    The European Academy of Dermatology and Venerelogy 30th Annual Congress (EADV) was packed with science and clinical practice updates. You can download the full report or read a brief look at some of the highlights.
    November 04, 2021
    PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes the first 1,272 cases.
    November 02, 2021
    The European Medicines Agency (EMA) has accepted to review Boehringer Ingelheim’s marketing authorization application (MAA) for spesolimab to treat flares in generalised pustular psoriasis (GPP).
    More News


    We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.